AAAAAA
Results:
1-7
|
Results: 7
Authors:
Shechter, Y
Goldwaser, I
Lavon, I
Gershonov, E
Mester, B
Mironchik, M
Patt, LP
Fridkin, M
Citation: Y. Shechter et al., A new approach for prolonging the half-life of peptides, proteins and low-molecular-weight drugs in vivo, DRUG FUTURE, 26(7), 2001, pp. 669-676
Authors:
Sun, Q
Sekar, N
Goldwaser, I
Gershonov, E
Fridkin, M
Shechter, Y
Citation: Q. Sun et al., Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism, AM J P-ENDO, 279(2), 2000, pp. E403-E410
Authors:
Goldwaser, I
Gefel, D
Gershonov, E
Fridkin, M
Shechter, Y
Citation: I. Goldwaser et al., Insulin-like effects of vanadium: basic and clinical implications, J INORG BIO, 80(1-2), 2000, pp. 21-25
Authors:
Goldwaser, I
Qian, S
Gershonov, E
Fridkin, M
Shechter, Y
Citation: I. Goldwaser et al., Organic vanadium chelators potentiate vanadium-evoked glucose metabolism in vitro and in vivo: Establishing criteria for optimal chelators, MOLEC PHARM, 58(4), 2000, pp. 738-746
Authors:
Gershonov, E
Goldwaser, I
Fridkin, M
Shechter, Y
Citation: E. Gershonov et al., A novel approach for a water soluble long-acting insulin prodrug: Design, preparation, and analysis of [(2-sulfo)-9-fluorenylmethoxycarbonyl](3)-insulin, J MED CHEM, 43(13), 2000, pp. 2530-2537
Authors:
Goldwaser, I
Li, JP
Gershonov, E
Armoni, M
Karnieli, E
Fridkin, M
Shechter, Y
Citation: I. Goldwaser et al., L-glutamic acid gamma-monohydroxamate - A potentiator of vanadium-evoked glucose metabolism in vitro and in vivo, J BIOL CHEM, 274(37), 1999, pp. 26617-26624
Authors:
Gershonov, E
Shechter, Y
Fridkin, M
Citation: E. Gershonov et al., New concept for long-acting insulin - Spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin, DIABETES, 48(7), 1999, pp. 1437-1442
Risultati:
1-7
|